Emyria’s data-backed cannabinoid treatments are changing lives
Emyria Limited (ASX: EMD) is an Australian drug development company that focuses on novel treatments for patients with unmet medical...
Emyria Limited (ASX: EMD) is an Australian drug development company that focuses on novel treatments for patients with unmet medical...